Marrone Bio Innovations Overview

Marrone Bio Innovations Cost of Revenue

Cost of Revenue analysis for MBII.

Quarterly Cost of Revenue

$4.89M

↑ 20.2% YoY

As of Mar 31, 2022

Annual Cost of Revenue (TTM)

$17.89M

↑ 40.51% YoY

Trailing 12 months ending Mar 31, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin